Their approach combines integrated computational tools, repurposing analysis, cheminformatics data, and RNA sequencing of Pkd1 KO mice at different disease stages in order to identify new drugs for ADPKD. The gene discussed is PKD1; the disease is autosomal dominant polycystic kidney disease.